Sparton Corporation

Sparton — Investor Presentation (September 2013)

25 slides from Sparton's investor presentation, Sep 17, 2013

  1. Slide 1: Investor Presentation

    Exhibit 99.1 INVESTOR PRESENTATION NYSE: SPA September 2013

  2. Slide 2: Safe Harbor Statement

    Safe Harbor Statement Certain statements herein constitute forward-looking statements within the meaning of the Securities Act of 1933, as amended and the Securities Exchange Act of 1934, as amended. When used herein, words such as “believe,” “expect,” “anticipate,” “project,” “plan,” “estimate,” “w

  3. Slide 3: Investment Considerations

    Investment Considerations Established 113 year old business with market leadership in defense and Growing medical sectors; 19% sales increase in fiscal 2013; 33% year-over- Business year adjusted EBITDA increase in fiscal 2013 Fiscal 2013: $ 1.17 Fiscal 2010: $ (0.40) Continued EPS Fiscal 2012: $ 0.

  4. Slide 4: Mission

    Mission Sparton will continue to differentiate itself as a premier supplier of sophisticated electromechanical devices, sub-assemblies and related services for highly regulated environments in the Medical, Military & Aerospace, and Industrial markets by leveraging and expanding its capabilities and

  5. Slide 5: Our Business

    Our Business • Sparton is in one single line of business called Electromechanical Devices • Sparton is currently segmented into three financial reporting business units Defense & Security Design and Manufacturing (both as a contractor and OEM) Medical Device Contract Design, Manufacturing, and Assem

  6. Slide 6: Strategically Located

    Strategically Located • Six domestic and one low-cost country manufacturing facilities – De Leon Springs, FL (Orlando) – Strongsville, OH (Cleveland) – Frederick, CO (Denver) – Brooksville, FL (Tampa) – Watertown, SD (Sioux Falls) – Birdsboro, PA (Philadelphia) – Ho Chi Minh City, Viet Nam – Sparton

  7. Slide 7: Senior Management Team

    Senior Management Team Cary B. Wood, Chief Executive Officer • Appointed CEO November 2008 • Formerly Chief Operating Officer of Citation Corporation, a private company with foundry, machinery and assembly operations with 20+ years of experience at GM, United Technologies & Elkay Manufacturing • Dev

  8. Slide 8: Market Dynamics

    Market Dynamics Electronics Market ($1.3 trillion) Total 2010 EMS/ODM Outsourced Market: $276 billion 2010 – 2013 Compounded Annual Growth Rate: 7.6% Military & Industrial & Medical Automotive Consumer Communication Computer Aerospace Instrumentation Highest growth High growth Moderate growth Modera

  9. Slide 9: Vision

    Vision Sparton will become a $500 million revenue entity by fiscal 2015 by attaining key market positions in our primary lines of business and through complementary and compatible acquisitions; and will consistently rank in the top half of our peer group in return on shareholder equity and return on

  10. Slide 10: Shifting Revenue Mix To Higher Margin Businesses

    Shifting Revenue Mix To Higher Margin Businesses FY2014 Target Gross Margin by Segment Backlog 10

  11. Slide 11: Defense & Security Systems

    Defense & Security Systems • Develop, design, and manufacture security products, primarily anti-submarine warfare detection devices for the U.S. and other free- world governments, and commercially develop spin-off technology for existing and alternate markets (Navigation & Exploration) • One of the

  12. Slide 12: Defense & Security Systems

    Defense & Security Systems Market Outlook • Government FY2009 production peak was realized primarily in Sparton’s FY2011 Reduced U.S. Navy sonobuoy production volume in Sparton’s FY2012 will be partially offset by the pursuit of new developmental engineering funds from the DoD for Antisubmarine Warf

  13. Slide 13: Medical

    Medical • Design and manufacture medical devices and instruments for the In Vitro Diagnostics and Therapeutics Device markets • Work with OEMs and biomedical companies to interface their core technology into a complex medical laboratory instrument or point of care device • Manufacturer of The NeuroS

  14. Slide 14: Complex Systems

    Complex Systems • Manufacturer of circuit card assemblies and electronic based box build products primarily for the military and commercial aerospace markets • New prototyping capabilities to shorten Circuit Board Sub Assembly development and introduction lead times for Assembly customers • Consolid

  15. Slide 15: Strategic Direction

    Strategic Direction Growth Planning by Segment Vision: Sparton will become a $500 million revenue entity with 10% EBITDA margins by fiscal 2015 by attaining key market positions in our primary lines of business and through complementary and compatible acquisitions; and will strive to be consistently

  16. Slide 16: Growth Investments

    Growth Investments Summary Focus: Use growth investments to achieve sustainable year-over-year revenue and profit increases and to further place protective barriers around Sparton. Acquisitions Fiscal 2011 Fiscal 2012 Fiscal 2013 Fiscal 2014 Delphi Medical None Onyx EMS Aydin Displays Byers Peak Cre

  17. Slide 17: Acquisition Updates

    Acquisition Updates • Creonix – Closed transaction on June 6, 2013 – Manufactures complex electromechanical devices and engineers and manufactures cables and wire harnesses for the Industrial and Military & Aerospace markets – $12 million of revenue – Purchase inventory and equipment for $2.1 millio

  18. Slide 18: Financial Highlights

    TA) iy) Sparton Financial Highlights

  19. Slide 19: Fiscal 2013 Highlights

    Fiscal 2013 Highlights • Awarded a total of 71 new business programs in our contract services business with potential annualized sales of $39 million. • Completed the acquisition of certain assets of Creonix, LLC and Onyx EMS, LLC. Onyx had net sales of $31.2 million, adjusted operating income of $0

  20. Slide 20: Consolidated Financial Results

    Consolidated Financial Results Fiscal 2013 (Reported) (Adjusted) (Adjusted) (Adjusted) (Adjusted) Fiscal ended June 30, Fiscal ended June 30, Total YoY Legacy YoY Onyx 2013 2012 2013 2012 Variance Variance Net Sales $ 266,015 $ 223,577 $ 266,015 $ 223,577 $ 42,438 $ 31,189 $ 11,249 Gross Profit 45,6

  21. Slide 21: Consolidated Financial Results

    Consolidated Financial Results Adjusted EBITDA Fiscal ended June 30, YoY 2013 2012 Variance Net Income $ 13,638 $ 9,508 $ 4,130 Interest expense 518 696 (178) Interest income (102) (94) (8) Provision for income taxes 2,763 5,078 (2,315) Depreciation and amortization 4,761 1,814 2,947 Restructuring/i

  22. Slide 22: Quarterly Adjusted EPS

    Quarterly Adjusted EPS Diluted 22

  23. Slide 23: Liquidity & Capital Resources

    Liquidity & Capital Resources Cash Availability ($ in '000) Jun-12 Sep-12 Dec-12 Mar-13 Jun-13 Cash and equivalents 46,950 43,096 6,066 4,358 6,085 LOC Availability 16,277 16,012 51,000 52,000 55,000 Total 63,227 59,108 57,066 56,358 61,085 Debt ($ in '000) Jun-12 Sep-12 Dec-12 Mar-13 Jun-13 Credit

  24. Slide 24: Fiscal 2014 Outlook

    Fiscal 2014 Outlook • Implementation of the strategic growth plan – Continue to grow organically – Maintain our level of investment in internal research & development to commercially extend our product lines – Continue to enable our engineering workforce to develop new and innovative proprietary sol

  25. Slide 25: Sparton Corporation

    Sparton Corporation NYSE: SPA Cary Wood, President & CEO 425 N. Martingale Road Suite 2050 Schaumburg, IL 60173 25

Sparton — Investor Presentation (September 2013) on 6ix